New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Clene Inc.
CLNN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

44M

Biotechnology

Next Earning date - 05 Nov 2024

44M

Biotechnology

Next Earning date - 05 Nov 2024

5.56USD
Shape0.22 ( 4.12%)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

-57%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated October 19, 2024
1W -3.30 % 1M 11.20 % 3M 23.83 % 1Y -44.18 %

Key Metrics

Shape
  • Market Cap

    44.27M


  • Shares Outstanding

    7.96M


  • Share in Float

    4.38M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    5.56


  • Average Volume

    132581


  • Beta

    0.475


  • Range

    3.82-12.0


  • Industry

    Biotechnology


  • Website

    https://clene.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

100.16x

P/S Ratio

-1417.18x

P/B Ratio

-55.7

Debt/Equity

-6890.5%

Net Margin

$-3.1

EPS

How CLNN compares to sector?

P/E Ratio

Relative Strength

Shape

CLNN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape4808%

2025-Revenue

$3.52

Shape-6560%

2025-EPS

$3M

Shape62%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

EF Hutton

initialise

Previous: Not converted

2024-09-10

Now: Buy

H.C. Wainwright

initialise

Previous: Not converted

2022-07-18

Now: Buy

Canaccord Genuity

initialise

Previous: Not converted

2022-05-02

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.14
vs -0.03

Q4.22

arrow
arrow

N/A

-0.16
vs -0.19

Q1.23

arrow
arrow

N/A

-0.15
vs -0.21

Q2.23

arrow
arrow

N/A

-0.12
vs -0.22

Q3.23

arrow
arrow

N/A

-0.02
vs -0.14

Q4.23

arrow
arrow

N/A

-0.06
vs -0.16

Q1.24

arrow
arrow

N/A

-1.80
vs -0.15

Q2.24

arrow
arrow

N/A

-1.06
vs -0.12

Q3.24

arrow
arrow

N/A

-1.30
vs -0.02

Q4.24

arrow
arrow

N/A

-0.96
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+58%

174K  vs 110K

Q4.22

arrow
arrow

+18%

234K  vs 199K

Q1.23

arrow
arrow

+257%

107K  vs 30K

Q2.23

arrow
arrow

+669%

269K  vs 35K

Q3.23

arrow
arrow

-38%

108K  vs 174K

Q4.23

arrow
arrow

-27%

170K  vs 234K

Q1.24

arrow
arrow

-32%

73K  vs 107K

Q2.24

arrow
arrow

-66%

91K  vs 269K

Q3.24

arrow
arrow

-1%

106.7K  vs 108K

Q4.24

arrow
arrow

-16%

143.3K  vs 170K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+130%

1.3
vs 8.05

Q4.22

arrow
arrow

+266%

2.66
vs 1.3

Q1.23

arrow
arrow

+853%

8.53
vs 2.66

Q2.23

arrow
arrow

-117%

-1.17
vs 8.53

Q3.23

arrow
arrow

-11%

-0.11
vs -1.17

Q4.23

arrow
arrow

-76%

-0.76
vs -0.11

Q1.24

arrow
arrow

-260%

-2.60
vs -0.76

Q2.24

arrow
arrow

+1346%

13.46
vs -2.60

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

54

54
vs 40

35%

Q4.22

arrow
arrow

40

40
vs 54

-26%

Q1.23

arrow
arrow

34

34
vs 40

-15%

Q2.23

arrow
arrow

53

53
vs 34

56%

Q3.23

arrow
arrow

49

49
vs 53

-8%

Q4.23

arrow
arrow

45

45
vs 49

-8%

Q1.24

arrow
arrow

47

47
vs 45

4%

Q2.24

arrow
arrow

39

39
vs 47

-17%

Earnings Growth

Latest News